Talk:Diabetes medication

Medicine High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
High	This article has been rated as High-importance on the project's importance scale.

Pharmacology Top‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Top	This article has been rated as Top-importance on the project's importance scale.

Review

PMID 17638715 may be helpful for an expansion. Fvasconcellos (t·c) 16:58, 21 September 2007 (UTC)[reply]

This has been added in detail to Diabetes mellitus type 2.Badgettrg 20:15, 23 September 2007 (UTC)[reply]

Question: where to place discussion of selecting anti-diabetic drugs?

The new insulin randomized controlled trial in NEJM (doi:10.1056/NEJMoa075392), along with the question above, raise the important point of where to discuss the trials that guide selecting a treatment regimen for diabetes? This discussion could legitimately go under Diabetes mellitus type 2, Anti-diabetic drug, or insulin. So we do not grow parallel content that is difficult to harmonize, I propose this content only go in one of these places with the other two places noting the discussion and linking to it. I would like to clarify this now before adding doi:10.1056/NEJMoa075392.

I propose this discussion go under Diabetes mellitus type 1 and Diabetes mellitus type 2, which is where most of the discussion is currently. Is this ok?
Badgettrg 20:21, 23 September 2007 (UTC)[reply]

Alternative/complementary treatments

The "Herbal extracts" section could use some expansion and better referencing. I was surprised to find no mention of Gymnema sylvestre, since it seems to be used widely, both traditionally (especially in India) and as a supplement, and a lot has been published on it (no RCTs, though). Fvasconcellos (t·c) 23:32, 19 November 2007 (UTC)[reply]

Well. Two years on, there is still no mention of Gymnema. I also find it odd that the article mentions Myrcia extracts and not Bauhinia fortificata (pata de vaca), which is arguably the most popular folk remedy for diabetes in Brazil (and for which there is ample evidence of efficacy in animal models), or Syzygium jambolanum, which is also very popular (and has been very extensively researched, although there is no clear-cut evidence to support its use). Fvasconcellos (t·c) 19:30, 18 August 2009 (UTC)[reply]

Testosterone

Testosterone is the most powerful and safe anti-diabetic drug and therefore I have inserted one paragraph —Preceding unsigned comment added by 158.194.199.13 (talk) 16:22, 18 October 2009 (UTC)[reply]

This is too POV "Testosterone deficiency (hypogonadism) can easily results in diabetes mellitus, therefore testosterone replacement therapy is proven to be very effective against diabetes mellitus type 2 because it reduces insulin resistance.^[1]^[2]"

References

^ Rice (2008). "Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach". The Diabetes educator. 34 Suppl 5: 97S–112S, quiz 113S–4S. doi:10.1177/0145721708327143. PMID 19020265. {{cite journal}}: |first2= missing |last2= (help); |first3= missing |last3= (help); |first4= missing |last4= (help); |first5= missing |last5= (help); |first6= missing |last6= (help); |first7= missing |last7= (help)
^ Corona (2009). "Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?". International journal of andrology. 32 (5): 431–41. doi:10.1111/j.1365-2605.2009.00965.x. PMID 19538523. {{cite journal}}: |first2= missing |last2= (help); |first3= missing |last3= (help); |first4= missing |last4= (help)

--Doc James (talk · contribs · email) 22:02, 20 December 2009 (UTC)[reply]

It is what the articles say! if you want you may also change the sentences, but leavineg the section —Preceding unsigned comment added by 83.225.44.181 (talk) 16:02, 22 December 2009 (UTC)[reply]

Which article said this? I looked at both of them and missed "most powerful and safe anti diabetic drug" Doc James (talk · contribs · email) 17:48, 22 December 2009 (UTC)[reply]

Just ignore this - rehash of indef blocked SPA Testosterone vs diabetes (talk · contribs) giving undue weight to primary sources, but not reflecting majority (general medical consensus) - anon sock block evasions are now being blocked and rehashed talk sections deleted: 83.225.44.181 (talk · contribs) & 93.68.107.68 (talk · contribs). David Ruben ^Talk 03:02, 23 December 2009 (UTC)[reply]

Anti-diabetic medications

Moving to this title as medication is the more accepted term Doc James (talk · contribs · email) 17:03, 9 January 2011 (UTC)[reply]

Late to the party, but I'm not at all sure this is a good idea. (Internationally, actually, "drug" or "medicine" are more widely accepted.) See my post over at WP:PHARM. Fvasconcellos (t·c) 19:15, 25 March 2011 (UTC)[reply]

Would support the use of medicine rather than medication. --Doc James (talk · contribs · email) 20:21, 25 March 2011 (UTC)[reply]

Comparison

I was going to edit the comparison table to remove "effective" from the advantages of secretagogues (metformin and the glitazones typically reduce A1C just as effectively) and add "inexpensive" to metformin (it's long been off-patent). But then I saw that the table was taken directly from a published source and I'm hesitant to tweak it. Suggestions? --Yaush (talk) 15:01, 5 October 2011 (UTC)[reply]

This direct quote seems very one-sided in summing up the controversy described in its paragraph: "This weak evidence for adverse effects has reduced the use of rosiglitazone, despite its important and sustained effects on glycemic control." I did a little looking around and find that Ajjan and Grant, to whom the quote is attributed (see footnote 15), disclose a business relationship with several manufacturers of the type of drug described in the controversy. See "Disclosure" in http://spo.escardio.org/eslides/view.aspx?eevtid=33&id=5118 , which mentions consulting fees and research paid for by a number of drug manufacturers. I would think that this sentence should be removed from this article, given the article's otherwise-apparent intent of objectivity. Robtrodes (talk) 01:13, 8 November 2013 (UTC)[reply]

hyphens

The hyphen should be removed from anti-diabetic in the title. The text has been edited as it was inconsistent. Just as antibiotic isn't hyphenated (nor is antihyperglycemic in the article), antidiabetic does not require hyphenation. MS Word doesn't like it, but that doesn't make it correct. The American Diabetes Association uses the nonhyphenated form. 72.1.68.18 (talk) 13:30, 9 September 2016 (UTC)KBoehm[reply]

Thanks for this note! I have reverted for now - we can discuss this and if we get consensus we'll rename the article and fix all the instances, all at once.

About your claim that ABA uses "antidiabetic"... we generally need sources, not just claims. So I looked.

"anti-diabetic" is used
- here (page aimed at the public on costs) and
- 2008 press release about huge clinical trial
"antidiabetic" is used:
- journal article they wrote on costs, on which the costs website is based
- 2013 press release about that costs study
- 2007 press release about different study

Small sample, but they are not consistent in any way that I can see.

MESH term is Hypoglycemic Agents; as synonyms they list:

Antidiabetics Antidiabetic Drugs Drugs, Antidiabetic Antidiabetic Agents Agents, Antidiabetic

I am in favor of using MESH terms as much as we can so I would support switching to the unhyphenated version... What do others think? Jytdog (talk) 17:47, 9 September 2016 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified one external link on Anti-diabetic medication. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

Added archive https://web.archive.org/web/20100109101501/http://www.novonordisk.com/science/about_rd/quarterly_rd_update.asp to http://www.novonordisk.com/science/about_rd/quarterly_rd_update.asp

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 07:56, 7 July 2017 (UTC)[reply]

serious problems with insulin classification list

Regular insulin, and so on are not rapid acting insulin. They are the modified insulins which begin to act within perhaps 15 minutes, and whose action is largely ended in something like an hour. Examples are lispro, aspart, ... This list is incorrect, and dangerously so. It should be corrected! 69.118.211.159 (talk) 10:25, 9 October 2018 (UTC)[reply]

Wiki Education assignment: PHMD 2040 Service - Learning Fall 2023

This article was the subject of a Wiki Education Foundation-supported course assignment, between 31 May 2023 and 29 December 2023. Further details are available on the course page. Student editor(s): Sofiaebeo (article contribs).

— Assignment last updated by Sofiaebeo (talk) 21:06, 15 March 2024 (UTC)[reply]

Tirzepatide (Mounjaro)

We need to include Tirzepatide as one of the recent medication to this article.I don't normally contribute to this article so would ask experienced editors to look into adding it.Thanks. Jonathansammy (talk) 17:26, 30 October 2024 (UTC)[reply]

[pubmed19020265-1] Rice (2008). "Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach". The Diabetes educator. 34 Suppl 5: 97S–112S, quiz 113S–4S. doi:10.1177/0145721708327143. PMID 19020265. {{cite journal}}: |first2= missing |last2= (help); |first3= missing |last3= (help); |first4= missing |last4= (help); |first5= missing |last5= (help); |first6= missing |last6= (help); |first7= missing |last7= (help)

[pmid19538523-2] Corona (2009). "Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?". International journal of andrology. 32 (5): 431–41. doi:10.1111/j.1365-2605.2009.00965.x. PMID 19538523. {{cite journal}}: |first2= missing |last2= (help); |first3= missing |last3= (help); |first4= missing |last4= (help)

[1]

[2]